Concepedia

Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma

Samuel Limat, Étienne Daguindau, J Cahn, Virginie Nerich, A. Brion, Sophie Perrin, M.‐C. Woronoff‐Lemsi, Éric Deconinck

Journal of Clinical Pharmacy and Therapeutics · 2014 · 57 citations · 25 references

DOI

Abstract

Our study confirmed the weight of cardiac toxic effect of CHOP ± R regimen. Even if the use of dexrazoxane is highly debatable in curative situations, it may be an effective prevention of cardiotoxicity in aggressive NHL patients.

References

25

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

NL Harris, ES Jaffe, H Stein et al. · Blood · 1994 · 6.3K citations · Full text

, , +9

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine · 2002 · 5.5K citations · Full text

World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues

D. K. Hossfeld · Annals of Oncology · 2002 · 4.6K citations · Full text

, , +11

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

Michael Pfreundschuh, Lorenz Trümper, Anders Österborg et al. · The Lancet Oncology · 2006 · 2.1K citations

, , +7

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

Bertrand Coiffier, Catherine Thiéblemont, Éric Van Den Neste et al. · Blood · 2010 · 1.5K citations · Full text